#None #Paris #Terumo Neuro #SOFIA Flow 88 #Stroke Management

Enhancing Stroke Care: Introduction of the SOFIA™ Flow 88 Catheter by Terumo Neuro

In a significant advancement for neurovascular treatment, Terumo Neuro has announced the launch of its latest neurovascular aspiration catheter, the SOFIA™ Flow 88, in the EMEA region. As a wholly owned subsidiary of Terumo Corporation, Terumo Neuro has established itself as a leader in neurovascular innovation, with a commitment to enhancing stroke management through reliable, effective solutions.

A Legacy of Innovation and Trust

The SOFIA™ Flow 88 catheter builds upon a decade of proven clinical performance and innovation. With more than 500,000 procedures supported across 170 countries, Terumo Neuro’s SOFIA™ family has earned the trust of physicians worldwide. The new catheter features a robust inner diameter of 0.088 inches. Its design incorporates proprietary technical enhancements that aim to improve procedural flexibility and control.

Carsten Schroeder, CEO of Terumo Neuro, emphasized the company’s dedication to ongoing innovation in neurovascular care. “By presenting the SOFIA™ Flow 88 aspiration catheter, we capitalize on ten years of performance that has instilled confidence in doctors globally. This launch reflects our continued investment into neurovascular innovation, made possible through direct collaboration with healthcare professionals and our strong R&D and manufacturing capabilities. Together, we are making significant advancements in the care of stroke victims, designed to improve outcomes for patients worldwide.”

Key Features and Benefits of SOFIA™ Flow 88

The SOFIA™ Flow 88 is designed with features that cater to the complexities of neurovascular procedures:

• - Reliable Targeting: Optimized transition zones and a soft, atraumatic distal tip enhance traceability within complex anatomies.
• - Proximal Stability: The catheter ensures operational ease with both short and long sheaths.
• - Atraumatic Design: Enhanced flexibility and reinforcement throughout the working length minimize vascular trauma, facilitating smoother navigation.
• - Confident Clot Capture: The patented SOFIA tip expands beyond the marking band to securely accommodate and capture clots.
• - Robust Aspiration Technology: The next-gen SOFIA design utilizes a braided nitinol structure and spiral reinforcement to maintain lumen integrity.

Integration with Existing Systems

The SOFIA™ Flow 88 is fully compatible with the SOFIA™ Plus 6F aspiration catheter, integrating seamlessly into existing aspiration strategies. Clinical trials assessing the SOFIA™ Plus have demonstrated robust outcomes in terms of speed, safety, and clinical effectiveness in treating patients with acute ischemic stroke. This compatibility underscores Terumo Neuro's commitment to comprehensive stroke care solutions that include not only aspiration catheters but also recovery devices such as the ERIC™ for effective thrombus control, the BOBBY™ balloon guide catheter for reliable flow occlusion, and the HEADWAY™ microcatheters for enhanced navigation capabilities.

Upcoming Presentations

The SOFIA™ Flow 88 is set to be showcased at LINNC Paris, an esteemed event dedicated to interventional neurovascular care, where Terumo Neuro will present a complete suite of products specifically designed for stroke management. Attendees can learn about the advantages and specifications of the new catheter and inquire about how it can be integrated into their practice.

Moving Forward

Terumo Neuro remains focused on redefining the standards of neurovascular care with its innovative lineup of products aimed at improving patient outcomes. The introduction of the SOFIA™ Flow 88 is a testament to the company’s commitment to forging new pathways in stroke treatment and establishing a lasting impact on patient health globally. For more information, visit Terumo Neuro.